Literature DB >> 15168140

Epidemiology and characterization of Bordetella parapertussis strains isolated between 1995 and 2002 in and around Warsaw, Poland.

I Letowska1, W Hryniewicz.   

Abstract

The aim of the study presented here was to analyze parapertussis infections occurring in the region of Warsaw, Poland, between 1995 and 2002 and to characterize the Bordetella parapertussis isolates using macrorestriction digestion of genomic DNA. Fourteen of the 17 patients with confirmed Bordetella parapertussis infection were between the ages of 5 and 9 years, and 14 had documented vaccination with the diphtheria-tetanus-pertussis whole-cell vaccine; for the remaining three patients vaccination data was not available. DNA fingerprinting performed using recommended standard methodology revealed a close relationship between the examined strains and reference strain ATCC 9305, thus confirming the conservative nature of Bordetella parapertussis.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15168140     DOI： 10.1007/s10096-004-1141-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  14 in total

1.  Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology.

Authors:  F R Mooi; H Hallander; C H Wirsing von König; B Hoet; N Guiso
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-03       Impact factor: 3.267

2.  Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains.

Authors:  Natacha Kourova; Valérie Caro; Christian Weber; Sabine Thiberge; Raisa Chuprinina; Galina Tseneva; Nicole Guiso
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

3.  PFGE and pertactin gene sequencing suggest limited genetic variability within the Finnish Bordetella parapertussis population.

Authors:  Johanna Mäkinen; Jussi Mertsola; Hanna Soini; Heikki Arvilommi; Matti K Viljanen; Nicole Guiso; Qiushui He
Journal:  J Med Microbiol       Date:  2003-12       Impact factor: 2.472

4.  Pertussis notifications in Australia, 1991 to 1997.

Authors:  R Andrews; A Herceg; C Roberts
Journal:  Commun Dis Intell       Date:  1997-05-29

5.  Return of epidemic pertussis in the United States.

Authors:  J W Bass; R R Wittler
Journal:  Pediatr Infect Dis J       Date:  1994-05       Impact factor: 2.129

6.  Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population.

Authors:  Q He; M K Viljanen; H Arvilommi; B Aittanen; J Mertsola
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

7.  Human but not ovine isolates of Bordetella parapertussis are highly clonal as determined by PCR-based RAPD fingerprinting.

Authors:  M H Yuk; U Heininger; G Martínez de Tejada; J F Miller
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

8.  Clinical and epidemiological picture of B pertussis and B parapertussis infections after introduction of acellular pertussis vaccines.

Authors:  J G Liese; C Renner; S Stojanov; B H Belohradsky
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

9.  Typing of sequential bacterial isolates by pulsed-field gel electrophoresis.

Authors:  A I Hartstein; P Chetchotisakd; C L Phelps; A M LeMonte
Journal:  Diagn Microbiol Infect Dis       Date:  1995-08       Impact factor: 2.803

10.  Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates.

Authors:  P Mastrantonio; P Stefanelli; M Giuliano; Y Herrera Rojas; M Ciofi degli Atti; A Anemona; A E Tozzi
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948
View more
  3 in total

1.  T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.

Authors:  Pascal Feunou Feunou; Julie Bertout; Camille Locht
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

2.  The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis.

Authors:  Xuqing Zhang; Elizabeth M Goebel; Maria Eugenia Rodríguez; Andrew Preston; Eric T Harvill
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

3.  The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.

Authors:  Daniel N Wolfe; Elizabeth M Goebel; Ottar N Bjornstad; Olivier Restif; Eric T Harvill
Journal:  Infect Immun       Date:  2007-08-13       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.